- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02713464
Does Maternal Instruction Prevent Kernicterus in Nigeria?
March 17, 2016 updated by: Richard Patridge Wennberg, Bilimetrix s.r.l.
Effect of Education on Prevalence of Kernicterus in Five Regions in Nigeria
This study examines (a) whether introduction of public, health provider, and maternal education about risks of jaundice will decrease the occurrence of ABE compared with baseline prevalence (before-after design) or (b) whether antenatal or postpartum instruction to mothers will decrease the incidence of ABE compared with those who did not received instruction (concurrent opportunistic controls in phase 2).
Study Overview
Detailed Description
This 2 phase study first determines the prevalence of acute bilirubin encephalopathy (ABE) among newborns admitted for treatment of jaundice at 5 regional centers in Nigeria and identifies social/behavioral/medical factors associated with ABE.
Information gained in phase 1 identified high risk sub-populations and guided selection of instructional materials for phase 2. Core data sheets submitted monthly by participating centers included clinical data, demographic information, number of antenatal clinic visits, birth place (hospital, clinic, home) and attendant, distance from care centers and reasons for delay, if any, in seeking care.
Receipt of jaundice instruction by mothers is self-reported.
Statistical analysis includes Chi square and logistic regression analysis of risk factors.
Sample size: 1,000 subjects in each phase are required to demonstrate a 20% decrease in disease prevalence (baseline ABE incidence anticipated to be 15% of jaundiced babies) at 95% confidence level.
Study Type
Interventional
Enrollment (Actual)
1765
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 minutes to 3 weeks (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Newborn infant receiving treatment for neonatal jaundice
Exclusion Criteria:
- Non-viable premature infants
- Severe congenital defects.
- Postnatal age greater than 21 days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: maternal education
Phase IIa: Pregnant women attending antenatal clinics or postpartum in clinics or hospital who receive programmed maternal education about risks and care of newborn jaundice.
|
Antenatal and/or postpartum Instruction on risks of neonatal jaundice, dangerous practices, technique to evaluate jaundice, early signs of ABE, when to seek care.
|
No Intervention: Historic control
Phase I: (before-after design) Baseline prevalence of acute bilirubin encephalopathy before maternal education instituted.
|
|
No Intervention: No intervention
Phase IIb: Opportunistic controls - infants of mothers who failed to receive education about risks and care of newborn jaundice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acute bilirubin encephalopathy
Time Frame: at time of admission or discharge (1-21 days of life)
|
Clinical signs of bilirubin toxicity described by unique neurological features in the presence of hyperbilirubinemia: reported as yes, no, or suspect (mild signs)
|
at time of admission or discharge (1-21 days of life)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Death from acute bilirubin encephalopathy or combined ABE/sepsis
Time Frame: 1-21 days of life
|
Clinical signs of severe bilirubin toxicity with or without clinical signs of sepsis
|
1-21 days of life
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Stephen Oguche, MBBS, Jos University Teaching Hospital
- Study Director: Abieyuwa Emokpae, MBBS, Massey Street Pediatric Hospital, Lagos
- Study Director: Zubaida Farouk, MBBS, Aminu Kano Teaching Hospital
- Study Director: Angela Okolo, MBBS, Federal Medical Center Asaba
- Study Director: Isa Abdulkadir, MBBS, Ahmadu Bello University Teaching Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009 Feb;29 Suppl 1:S25-45. doi: 10.1038/jp.2008.211.
- Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med. 2010 Jun;15(3):157-63. doi: 10.1016/j.siny.2009.12.004. Epub 2010 Jan 29.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
March 12, 2016
First Submitted That Met QC Criteria
March 17, 2016
First Posted (Estimate)
March 18, 2016
Study Record Updates
Last Update Posted (Estimate)
March 18, 2016
Last Update Submitted That Met QC Criteria
March 17, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SKIN1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kernicterus
-
University of MinnesotaCompletedHyperbilirubinemic EncephalopathyNigeria
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)Recruiting
-
Kettering Health NetworkBilimetrix s.r.l.RecruitingKernicterus | Point-of-Care Testing | Neonatal Screening | Newborn JaundiceUnited States
-
Stanford UniversitySmith-Kettlewell Eye Research InstituteCompletedHyperbilirubinemia | Infant, Premature | Infant, Low Birth Weight | Kernicterus | Bilirubin-induced Neurologic DysfunctionUnited States
-
Children's Hospital of Fudan UniversityShanghai 6F+ Early intervention center for high risk preterm infantsWithdrawnCerebral Infarction | Intraventricular Hemorrhage | Hypoxic-Ischemic Encephalopathy | Periventricular Leukomalacia | Kernicterus | Bilirubin Encephalopathy | Hypoglycemia, NeonatalChina
-
Children's Hospital of Fudan UniversityShanghai High-risk Infants Early Intervention CenterTerminatedCerebral Infarction | Hypoxic-Ischemic Encephalopathy | Periventricular Leukomalacia | Kernicterus | Bilirubin Encephalopathy | Hypoglycemia, Neonatal | Intraventricular Hemorrhage NeonatalChina
Clinical Trials on maternal education
-
Jimma UniversityWachemo UniversityRecruitingMaternal HealthEthiopia
-
University of California, DavisNational Institute of Mental Health (NIMH)Completed
-
Emory UniversityKaiser PermanenteCompleted
-
KTO Karatay UniversityKAMİLE ALTUNTUĞRecruitingMaternal-Fetal Relations | Maternal BehaviorTurkey
-
University of DoualaCompleted
-
lliana Ulloa SabogalUnknownBreastfeeding, ExclusiveColombia
-
Aga Khan UniversityCompleted
-
Ariel UniversityCompletedPregnancy Related | Delivery ComplicationIsrael
-
National Yang Ming UniversityRecruiting
-
Hospital Universitari Vall d'Hebron Research InstituteUniversity of BarcelonaUnknownPersistent Occiput Posterior Position During LaborSpain